In agreement with all these data, there is an increasing number of studies reporting the relationship of IKKα signaling to the development of different types of neoplasias: breast cancer [14]; hepatocarcinomas [15]; prostate cancer [17], and colorectal cancer [18]. Here, CHUK is linked to breast cancer.